THE NICKLES GROUP, LLC for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Monitored FY2022 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| RACHEL JONES HENSLER | — |
Health Issues HCR
Monitored issues related to COVID, including therapeutics and the drug supply chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
Government Issues GOV
Issues related to COVID-19 and issues related to the reimbursement of self-administered drugs. Monitored issues related to COVID, including therapeutics and the drug supply chain. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, the Lower Costs, More Cures Act. Monitored issues related to CAR-T cell therapy access and reimbursement. Monitored FY 2022 Budget Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER New | U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff |
Medicare/Medicaid MMM
Issues related to COVID-19 and issues related to the reimbursement of self-administered drugs. Issues related to CAR-T cell therapy access and reimbursement. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S. 2164, the Lower Costs, More Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
Taxation/Internal Revenue Code TAX
Monitored the American Jobs Plan, as it relates to corporate taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.